Publicaciones en las que colabora con José María Miró Meda (10)

2014

  1. Delayed HIV diagnosis and initiation of antiretroviral therapy: Inequalities by educational level, COHERE in EuroCoord

    AIDS, Vol. 28, Núm. 15, pp. 2297-2306

2013

  1. Predictors of CD4+ T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes

    Journal of Infectious Diseases, Vol. 207, Núm. 5, pp. 759-767

  2. Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

    PLoS Medicine, Vol. 10, Núm. 9

  3. The incidence of AIDS-defining illnesses at a current CD4 count ≥200 cells/μL in the post-combination antiretroviral therapy era

    Clinical Infectious Diseases, Vol. 57, Núm. 7, pp. 1038-1047

2012

  1. CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: A longitudinal cohort study from COHERE

    PLoS Medicine, Vol. 9, Núm. 3

  2. Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: A cohort study

    The Lancet Infectious Diseases, Vol. 12, Núm. 2, pp. 119-127

2011

  1. Risk of triple-class virological failure in children with HIV: A retrospective cohort study

    The Lancet, Vol. 377, Núm. 9777, pp. 1580-1587

2010

  1. Is it safe to discontinue primary pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 Cell Count <200 Cells/μL?

    Clinical Infectious Diseases, Vol. 51, Núm. 5, pp. 611-619

2009

  1. Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

    AIDS, Vol. 23, Núm. 15, pp. 2029-2037

2008

  1. Response to combination antiretroviral therapy: Variation by age

    AIDS, Vol. 22, Núm. 12, pp. 1463-1473